Cofactor Genomics, Inc.

This study planned to check if a special test, called OncoPrism-HNSCC, could predict how well immunotherapy would work in people with head and neck cancer. Researchers wanted to compare test results with actual treatment outcomes. However, the study was withdrawn before enrolling…